Skip to main content
INO
NASDAQ Life Sciences

Inovio Plans Fresh Equity Raise Days After First FDA Approval

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.435
Mkt Cap
$149.926M
52W Low
$0.563
52W High
$2.72
52W Position info
155% above low
Off High info
47% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

INO has more than doubled off its 52-week low of $0.563.

Summary

Inovio is going back to the equity market with an underwritten common stock offering, with Jefferies and Piper Sandler acting as joint book-running managers, and it is not disclosing the size or price yet. Underwriters get a 30-day option for up to 15% of the offered shares, so the final dilution could be larger than the base deal. The timing is the story: this comes days after the FDA granted accelerated approval to VOCERYQ (INO-3107) on October 30, and after an $80.4M court judgment against VGXI and GeneOne on October 20. The company entered Q2 with a going concern warning and cash runway only into late Q1 2027, so a raise was expected — but selling stock into the post-approval pop transfers the upside to new buyers at the expense of existing holders. The preliminary prospectus supplement will set the share count and price; that filing is where the real dilution math shows up.

At the time of this announcement, INO was trading at $1.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $149.9M. The 52-week trading range was $0.56 to $2.72. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

INO - Latest Insights

INO
Nov 10, 2026, 4:05 PM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.46
Real-time Price: $1.84 info
Change: +$0.380 (+26%) info
Market Cap: $329.66M info
INO
Nov 10, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.47
Real-time Price: $1.84 info
Change: +$0.370 (+25%) info
Market Cap: $329.66M info
INO
Nov 09, 2026, 7:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.37
Real-time Price: $1.84 info
Change: +$0.470 (+34%) info
Market Cap: $329.66M info
INO
Nov 06, 2026, 4:30 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.21
Real-time Price: $1.84 info
Change: +$0.630 (+52%) info
Market Cap: $329.66M info
INO
Nov 05, 2026, 11:19 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $1.84 info
Change: +$0.6106 (+50%) info
Market Cap: $329.66M info